This article has been updated from a previous version to add comments from Qiagen's Q1 earnings call.

NEW YORK (GenomeWeb) – Qiagen reported after the close of the market on Tuesday that its first quarter revenues rose 3 percent, bolstered by increases in sales from every business except instruments.

For the three months ended March 31, the company reported revenues of $307.7 million, up from $298.4 million a year ago, and beating the average Wall Street estimate of $306.9 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.